European stocks lose ground as earnings hold the spotlight; Rheinmetall gains 2%

European stocks edged lower amid a flurry of mixed corporate earnings reports. AstraZeneca posted better-than-expected Q3 revenues but maintained cautious guidance due to China and Latin America headwinds, while Rheinmetall saw operating profit surge on defense orders despite a slight sales miss. Conversely, Diageo cut its full-year guidance citing weakness in Chinese and U.S. markets, and CommerzBank reported an unexpected Q3 net profit decline. Concurrently, the Bank of England and Norway's central bank held interest rates steady, impacting UK gilt yields and the pound, while U.S. markets anticipate a potential Supreme Court ruling against Trump-era tariffs that could boost equities.

Analysis

European equities experienced a mixed trading session, with the pan-European Stoxx 600 down 0.07% amidst a flurry of corporate earnings. AstraZeneca (AZN) reported better-than-expected Q3 revenues, up 10% year-on-year on a constant currency basis, but maintained a cautious full-year guidance citing headwinds in China and Latin America, leading to a modest 0.3% share gain. German defense contractor Rheinmetall also saw its shares rise 2.2% after a 20% year-on-year increase in operating profit to €360 million, driven by strong weaponry sales to NATO and Ukraine, despite Q3 sales slightly missing estimates. DHL also beat Q3 estimates, with shares up 5.6%, though its CEO noted a significant decline in U.S. trading volumes.

Conversely, Diageo (DEO) shares fell 6% after the company cut its full-year guidance, attributing the revision to weakness in the Chinese and U.S. markets and a projected $200 million impact from U.S. tariffs. German lender CommerzBank also saw a 2.9% decline following a surprise 7.9% year-on-year fall in Q3 net profit to €591 million, impacted by a tax effect and €553 million in restructuring costs, although it did raise its full-year net interest income guidance to €8.2 billion.

In monetary policy, both the Bank of England and Norway's central bank held key interest rates steady, a widely anticipated move for the BoE, which led to a nearly 3 basis point drop in the UK 10-year gilt yield. Broader market sentiment is also influenced by potential shifts in U.S. trade policy, with expectations of a Supreme Court ruling against Trump-era tariffs possibly boosting equities.

Key Decisions for Investors

• Investors should monitor AstraZeneca's (AZN) ability to navigate China and Latin America headwinds, as its cautious guidance may present an opportunity for overdelivery if conditions improve.
• Consider the implications of Diageo's (DEO) guidance cut, which highlights persistent demand weakness in key markets and tariff impacts, suggesting continued pressure on its outlook.
• Evaluate Rheinmetall's sustained growth in defense, driven by geopolitical demand, while noting CommerzBank's improved net interest income outlook despite a Q3 profit miss due to specific items.
• The stability in European interest rates and potential U.S. tariff rollbacks could offer broader market support, warranting attention to sectors sensitive to trade policy and economic stability.